Clinical Trial Update: Efficacy of Gralise® for Chronic Pelvic Pain [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Gralise (gabapentin ER) for chronic pelvic pain was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Irritable Bowel Syndrome
• Pelvic Pain
• Prostatitis
• Ulcerative Colitis

Drugs mentioned

• GRALISE (gabapentin)

Snippet

Sponsor: Shirley Ryan AbilityLab | Conditions: Irritable Bowel Syndrome, Ulcerative Colitis | Phase 4 | Status: TERMINATED | Results posted: 2015-06-29